Which laboratory parameter must be closely monitored to detect nephrotoxicity in a patient receiving gentamicin aminoglycoside therapy?
Answer and explanation
Correct answer: B. Serum creatinine and trough drug concentrations
Answer: Serum creatinine and trough drug concentrations.
Why not the others: Amylase and lipase monitor pancreatic disorders; Alkaline phosphatase and bilirubin assess hepatic and biliary disorders; Prothrombin time and platelets evaluate coagulation and hemostasis rather than renal proximal tubule injury.
Why not the others: Amylase and lipase monitor pancreatic disorders; Alkaline phosphatase and bilirubin assess hepatic and biliary disorders; Prothrombin time and platelets evaluate coagulation and hemostasis rather than renal proximal tubule injury.
Practise more Applied Clinical Pharmacology, Dosages and Fluid Balance.
Free questions with an explanation for every one, and full timed MOH Prometric mock tests.
More Applied Clinical Pharmacology, Dosages and Fluid Balance questions
- A physician orders 1,000 mL of 0.9% Normal Saline to be infused intravenously over 8 hours. The infusion set delivers 15 drops per mL (gtt/m…
- A pediatric patient weighing 18 kg requires oral Amoxicillin suspension prescribed at 40 mg/kg/day divided into two equal doses every 12 hou…
- A patient is receiving an intravenous infusion of regular insulin for diabetic ketoacidosis. The nurse knows that as blood glucose decreases…
- A patient with severe hypertension is prescribed intravenous Sodium Nitroprusside infusion in the ICU. The nurse observes that the infusion…
- A registered nurse is preparing to administer intramuscular Haloperidol. The physician's order reads: 'Haloperidol 7.5 mg IM stat'. The ampo…
- A patient on long-term Spironolactone therapy for congestive heart failure is prescribed an ACE inhibitor (Lisinopril) for refractory hypert…